So, this article talks about four companies that people can buy small parts of. These companies are called Collective Audience, BioCorRx, Coeptis Therapeutics and another one not mentioned in the title. Some important people who work at these companies or have a lot of knowledge about them bought more parts of the companies. This is a good sign because it means they think the company will do well and make money. The article also tells us what each company does and some news about them. Read from source...

1. The article is titled "Collective Audience And 3 Other Stocks Under $1 Insiders Are Buying", but it only covers four stocks, not five. This shows a lack of attention to detail and accuracy in the title.
2. The author uses vague terms like "insiders" without specifying who they are or what their roles are within the companies. This makes it unclear whose buying actions are relevant and why they should be taken as indicators of potential investment opportunities.
3. The article does not provide any context for why these stocks were chosen, how they performed in the past, or what factors might influence their future performance. This leaves readers without a clear understanding of the underlying reasons for the insider buying activity and whether it is justified by market conditions or personal interests.
4. The author mentions that Collective Audience named a new COO, but does not explain how this appointment affects the company's strategy, performance, or outlook. This omission suggests a lack of research or understanding of the implications of the executive change for the company and its stakeholders.
5. The article includes a premarket coverage link at the end, which seems irrelevant to the main topic and might confuse readers who expect more information about the stocks discussed in the article. This also implies that the author is trying to drive traffic to another source rather than providing comprehensive and valuable insights on the subject matter.